CEO Today USA Awards

www.ceotodaymagazine.com 88 CEO Today USAAwards 2018 NEW JERSEY STEVEN M. KLOSK President & CEO of Cambrex FIRM PROFILE Cambrex is an innovative life sciences company with a refreshingly human approach. Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years of active pharmaceutical ingredient (API) development and manufacturing expertise, a growing team of more than 1,200 experts and a strong presence in the USA and Europe, we are tried and trusted across branded and generic API markets. We put all of our energy and experience into being your partner of choice We create value for customers through manufacturing excellence, reliable quality and innovative science Our people are the experts that our customers enjoy working with We truly offer our customers an end-to-end partnership for the research, development and manufacture of small molecule APIs at every stage of the lifecycle. Our people are passionate about solving your API challenges and are driven by the Cambrex mission: Through innovative science and manufacturing excellence, we enable our customers to improve quality of life for their patients throughout the world, while creating value for our employees and shareholders. At Cambrex, we live and work by a set of values that help to make us refreshingly different. Customer focus: We listen to our customers to create solutions for their needs Innovation: We develop new and unique ideas to generate greater opportunities Integrity: We believe that integrity is the foundation of our success Passion to win: We strive to be the best and push ourselves to achieve superior results for our customers Quality: We deliver quality in every aspect of our work Safety: We aspire to achieve zero workplace accidents across our organization www.cambrex.com ABOUT STEVEN M. KLOSK Mr. Klosk joined Cambrex in 1992 and was elected President and Chief Executive Officer and became a member of the Board in May 2008. In 2007 he was appointed Executive Vice President and Chief Operating Officer and assumed the responsibility of the Pharmaceutical business. Between 2005 and 2007, Mr. Klosk served as Executive Vice President and Chief Operating Officer of the Pharma and BioPharmaceutical Business Unit. Between 1992 and 2005, he held positions of increasing responsibility including Executive Vice President- Administration.